TOPO-TBProject reference: 698260
Funded under :
H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and well-being
Total cost:EUR 71 429
EU contribution:EUR 50 000
Topic(s):PHC-12-2015-1 - Clinical research for the validation of biomarkers and/or diagnostic medical devices
Call for proposal:H2020-SMEINST-1-2015See other projects for this call
Funding scheme:SME-1 - SME instrument phase 1
Tuberculosis (TB) remains a major global health problem with 9 million new TB cases and 1.5 million TB deaths in 2013.
Given that with a wide health care access to diagnosis, most deaths are preventable, TB mortality is still unacceptably high.
With TOPO-TB the aim is to develop the first rapid diagnostic kit based on detection of the activity of an essential enzyme of the bacteria. A high degree of simplicity and low cost, in combination with mycobacteria detection in non-sputum samples, will enable TOPO-TB to achieve high impact on Tuberculosis control and elimination. Importantly, the low resource adaptable format meets the requirements of highly competitive TB test, complementing state-of-the-art methods for detection at the point of care patient level.
EU contribution: EUR 50 000
8200 AARHUS N